StockWatch
·

VIVIMED LABS LTD. Q3 FY25 Results

VIVIMEDLABQ3 FY25 Results
Filing
MetricValue ( Cr)vs Q2 FY25
Revenue36.5147.4%
Total Income36.5847.5%
Expenditure42.5542.1%
PBT-5.9716.2%
Net Profit-5.9716.2%
OPM-35.99%3.15pp
NPM-16.34%4.39pp
EPS-0.7220.0%
View full financials

Informational and educational content only. Not investment advice.